Dergilev Konstantin, Beloglazova Irina, Tsokolaeva Zoya, Azimova Ekaterina, Dolgodvorova Aleria, Goltseva Yulia, Boldyreva Maria, Menshikov Mikhail, Penkov Dmitry, Parfyonova Yelena
Institute of Experimental Cardiology Named after Academician V.N. Smirnov, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Solnechnogorsk District, v. Lytkino, 141534 Moscow, Russia.
Int J Mol Sci. 2025 Jul 28;26(15):7298. doi: 10.3390/ijms26157298.
Epicardial mesothelial cells (EMCs), which form the epicardium, play a crucial role in cardiac homeostasis and repair. Upon damage, EMCs reactivate embryonic development programs, contributing to wound healing, progenitor cell amplification, and regulation of lymphangiogenesis, angiogenesis, and fibrosis. However, the mechanisms governing EMC activation and subsequent regulation remain poorly understood. We hypothesized that hepatocyte growth factor (HGF), a pleiotropic regulator of various cellular functions, could modulate EMC activity. To verify this hypothesis, we developed HGF-overexpressing mesenchymal stromal cell sheets (HGF-MSC CSs) and evaluated their effects on EMCs in vitro and in vivo. This study has revealed, for the first time, that EMCs express the c-Met (HGF receptor) on their surface and that both recombinant HGF and HGF-MSC CSs secretome cause c-Met phosphorylation, triggering downstream intracellular signaling. Our findings demonstrate that the HGF-MSC CSs secretome promotes cell survival under hypoxic conditions by modulating the level of autophagy. At the same time, HGF-MSC CSs stimulate EMC proliferation, promoting their amplification in the damage zone. These data demonstrate that HGF-MSC CSs can be considered a promising regulator of epicardial cell activity involved in heart repair after ischemic damage.
构成心外膜的心外膜间皮细胞(EMCs)在心脏内环境稳态和修复中发挥着关键作用。受损时,EMCs会重新激活胚胎发育程序,促进伤口愈合、祖细胞扩增以及淋巴管生成、血管生成和纤维化的调节。然而,控制EMC激活及后续调节的机制仍知之甚少。我们推测,作为多种细胞功能的多效性调节剂,肝细胞生长因子(HGF)可能会调节EMC活性。为验证这一假设,我们开发了过表达HGF的间充质基质细胞片(HGF-MSC CSs),并在体外和体内评估了它们对EMCs的影响。本研究首次揭示,EMCs在其表面表达c-Met(HGF受体),并且重组HGF和HGF-MSC CSs的分泌组均会导致c-Met磷酸化,触发下游细胞内信号传导。我们的研究结果表明,HGF-MSC CSs的分泌组通过调节自噬水平促进缺氧条件下的细胞存活。同时,HGF-MSC CSs刺激EMC增殖,促进其在损伤区域的扩增。这些数据表明,HGF-MSC CSs可被视为缺血性损伤后参与心脏修复的心外膜细胞活性的一种有前景的调节剂。